• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
WANG Hang, FENG Fang, WANG Xue-qua. Chemical constituents of Zhizidahuang decoction detected by HPLC-PDA-ESI-MS/MS[J]. Journal of China Pharmaceutical University, 2009, 40(3): 232-237.
Citation: WANG Hang, FENG Fang, WANG Xue-qua. Chemical constituents of Zhizidahuang decoction detected by HPLC-PDA-ESI-MS/MS[J]. Journal of China Pharmaceutical University, 2009, 40(3): 232-237.

Chemical constituents of Zhizidahuang decoction detected by HPLC-PDA-ESI-MS/MS

More Information
  • Aim :To investigate the chemical components in Zhizidahuang decoction(ZZDHD) to reveal the possible material therapeutic basis. Methods :High performance liquid chromatography coupled with photodiode array detector and tandem mass spectrometry(HPLC-PDA-MS/MS) was applied to simultaneously characterize the chemical components and their structures in ZZDHD.The analysis was preformed on a Lichrospher C18 column using a binary eluent of 0.1% acetic acid(A) and methanol(B) mixed under the gradient mode;UV spectra were scaned from 210 nm to 480 nm;negative ESI experiments in data-dependent scan mode were performed. Results :HPLC-PDA-MS/MS chromatogram of ZZDHD was achieved.Based on UV spectral data,information of molecular weight and mass fragmentation behaviors connected with extracted ion current(EIC) chromatogram,twenty kinds of components were detected and identified,including flavonoids,anthraquinones,iridoids and other constituents. Conclusion :The method presented in this study,which combined HPLC with UV and MS,allowes the characterization of compounds in the complex herbal system even without the reference standards.
  • Related Articles

    [1]CHU Xuxin, BU Fanxue, YIN Tingjie, HUO Meirong. Antitumor strategies based on targeted modulation of tumor-associated macrophages[J]. Journal of China Pharmaceutical University, 2021, 52(3): 261-269. DOI: 10.11665/j.issn.1000-5048.20210301
    [2]SUN Xiaofeng, LIU Tao, LING Yun, CHEN Zhengwei, PAN Zihao, XU Zite, LUO Ling. Advances in research of hyaluronic acid modified nanomicelles for targeting tumor therapy and drug release behavior[J]. Journal of China Pharmaceutical University, 2019, 50(6): 641-647. DOI: 10.11665/j.issn.1000-5048.20190602
    [3]WANG Tianshuai, YU Junjie, ZHANG Yan, ZENG Jinjin, CUI Jingxin. Advances in platinum-intercalators of DNA as antitumor agents[J]. Journal of China Pharmaceutical University, 2019, 50(5): 505-515. DOI: 10.11665/j.issn.1000-5048.20190501
    [4]WANG Letian, WANG Jinglin, LIU Hongwu, GE Ying, LI Yuyan, XU Qingxiang. Process in targeted contrast agents for cancer imaging[J]. Journal of China Pharmaceutical University, 2017, 48(6): 635-645. DOI: 10.11665/j.issn.1000-5048.20170602
    [5]LU Xiaolin, ZHENG Ying, QIU Yang, ZHOU Xiang, LU Tao. Small conjugate-based theranostic agents:a tumour microenvironment responsive approach for cancer therapy[J]. Journal of China Pharmaceutical University, 2016, 47(6): 629-638. DOI: 10.11665/j.issn.1000-5048.20160601
    [6]ZHAO Yuekui, TANG Shanshan, ZHANG Yanfeng, ZONG Li, JIN Liang. Engineered mesenchymal stem cells as targeting therapeutic carriers in cancer therapy[J]. Journal of China Pharmaceutical University, 2016, 47(2): 134-139. DOI: 10.11665/j.issn.1000-5048.20160202
    [7]WANG Zhiqiang, WANG Xuemin, ZHANG Wei, WANG Xinyang, LING Yong, CHEN Li. Synthesis and biological evaluation of novel farnesylthiosalicylic acid/hydro-xylcinnamic acid hybrids as potential antitumor agents[J]. Journal of China Pharmaceutical University, 2014, 45(4): 392-399. DOI: 10.11665/j.issn.1000-5048.20140402
    [8]CHENG Haibo, XU Bin, ZHANG Huibin, ZHOU Jinpei. Synthetic process of antitumor drug dacomitinib[J]. Journal of China Pharmaceutical University, 2014, 45(2): 165-169. DOI: 10.11665/j.issn.1000-5048.20140206
    [9]LI Linhu, CHEN Li, XIA Yufeng. Progress in the study of coumarin derivatives as antitumor agents[J]. Journal of China Pharmaceutical University, 2013, 44(4): 374-379. DOI: 10.11665/j.issn.1000-5048.20130417
    [10]Cooperative Effects of Monkshood Polysaccharide with Adriamycin Magnetic Albumin Microsphere Targeting Therapy on Tumor[J]. Journal of China Pharmaceutical University, 2003, (6): 68-72.

Catalog

    Article views (1551) PDF downloads (1073) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return